Estrogen carcinogenesis in hamster tissues: A critical review

Endocrine Reviews

Volumn 11, Issue 4, 1990, Pages 524-531

  Li, Jonathan J ^a   Li, Sara Antonia ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ANIMAL CELL; ANIMAL TISSUE; CARCINOGENESIS; CONTROLLED STUDY; HAMSTER; KIDNEY; LIVER; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMAL; ESTROGENS; HAMSTERS; KIDNEY; KIDNEY NEOPLASMS; LIVER; LIVER NEOPLASMS; NEOPLASTIC ENDOCRINE-LIKE SYNDROMES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025223739     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-11-4-524     Document Type: Article

References (87)

1. Li JJ, Nandi S 1990 Hormones and carcinogenesis: laboratory studies. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. JB Lippincott Co, Philadelphia, chap 225,p 1643
2. Li JJ, Talley DJ, Li SA, Villee CA 1976 Receptor characteristics of specific estrogen binding in the renal adenocarcinoma of the golden hamster. Cancer Res 376:1127
3. Gottschlich R, Metzler M 1980 Metabolic fate of diethylstilbestrol in Syrian golden hamster, a susceptible species for diethylstilbestrol carcinogenicity. Xenobiotica 10:317
4. Nawata H, Yamamoto RS, Poirer A 1981 Elevated levels of ornithine decarboxylase and polyamines in the kidney of estradiol-treated male hamsters. Carcinogenesis 2:1207
5. Li JJ, Li SA 1984 Estrogen-induced tumorigenesis in the Syrianhamster: roles for hormonal and carcinogenic activities. Arch Toxicol 55:110
6. Liehr JG 1984 Modulation of estrogen-induced carcinogenesis by chemical modifications. Arch Toxicol 55:119
7. Li JJ, Li SA 1980 High incidence of hepatocellular carcinoma after synthetic estrogen administration in Syrian hamsters fed cv-naph-thoflavone: a new tumor model. J Natl Cancer Inst 73:543
8. Blaich G, Raabe H, Metzler M 1990 Modification of 7,8-benzofla-vone metabolism in hamster liver and kidney microsomes by hepatic tumor inducing treatments. Carcinogenesis 11:95
9. Li JJ, Li SA, Oberley TD, Goldfarb S, Pugh TA, Haaf H 1988 Estrogen carcinogenicity: hormonal, morphologic, and chemical interactions. In: Politzer PA, Roberts L (eds) Chemical Carcinogens. Elsevier Science Publishers, Amsterdam, The Netherlands, chap 13, p 312
10. Li JJ, Li SA 1987 Estrogen carcinogenesis in hamster tissues: role of metabolism. Fed Proc 46:1858
11. Kirkman H, Bacon RL 1950 Malignant renal tumors in male hamsters (Cricetus auratus) treated with estrogen. Cancer Res 10:122
12. Kirkman H 1959 Estrogen-induced tumor of the kidney in the Syrian hamster. J Natl Cancer Inst Monograph 1:1
13. Pour P, Mohr U, Althoff J, Cardesa A, Kmoch N 1976 Spontaneous tumors and common diseases in two colonies of Syrian hamsters III. Urogenital system and endocrine glands. J Natl Cancer Inst 56:949
14. Pour P, Althoff J, Salmasi SZ, Stephen K 1979 Spontaneous tumors and common diseases in three types of hamsters. J Natl Cancer Inst 63:797
15. Reznik-Schuuler H 1979 Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters. J Natl Cancer Inst 62:1083
16. Li SA, Li JJ, Villee CA 1977 Significance of the progesterone receptor in the estrogen-induced and dependent renal tumor of the Syrian golden hamster. Ann NY Acad Sci 286:369
17. Antonio P, Gabaldon M, Lacomba T, Juan A 1974 Effect of theanti-estrogen nafoxidine on the occurrence of estrogen-dependent renal tumors in hamsters. Horm Metab Res 6:522
18. Li JJ, Cuthbertson TL, Li SA 1980 Inhibition of estrogen carcinogenesis in the Syrian golden hamster kidney by antiestrogens. J Natl Cancer Inst 64:795
19. Li JJ, Li SA 1989 Preventio of estrogen carcinogenesis in hamster kidney by concomitant treatment with ethinylestradiol. Proc Am Assoc Cancer Res 30:171
20. Liehr JG, Wheeler WJ 1983 Inhibition of estrogen-induced renal carcinoma in Syrian hamsters by vitamin C. Cancer Res 43:4638
21. Haff H, Metzler M, Li JJ, Metabolism of natural estrogens in hamster and rat renal and hepatic microsomes: tissue, sex, and age specific differences. J Steroid Biochem, in press
22. Haff H, Li SA, Li JJ 1987 Covalent binding of estrogen metabolites to Syrian hamster liver microsomal proteins: inhibition by ascorbic acid and catechol-O-methyltransferase. Carcinogenesis 8:209
23. Li SA, Lam LKT, Li JJ 1983 Effect of steroid hormone treatment on aryl hydrocarbon hydroxylase activity in the Syrian hamster kidney. Biochem Pharmacol 32:2847
24. Li SA, Klicka JK, Li JJ 1985 Estrogen 2-/4-hydroxylase activity, catechol estrogen formation and implications for estrogen carcinogenesis. Cancer Res 45:181
25. Li SA, Klicka JK, Li JJ 1986 Regulation of estrogen 2-/4-hydroxylase activity in hamster kidney by estrogens and androgens. Endocrinology 119:1810
26. Li JJ, Li SA, Klicka JK, Parsons JA, Lam LKT 1983 Relative carcinogenic activity of various synthetic and natural estrogens in the hamster kidney. Cancer Res 43:5200
27. Liehr JG, DaGue BB, Ballatore AM, Henkin T 1983 Diethylstil-bestrol (DES) quinone: a reactive intermediate in DES metabolism. Biochem Pharmacol 32:3711
28. Metzler M, Epe B 1984 Peroxidase mediated finding of diethylstil-bestrol analogues to DNA in vitro: a possible role for a phenoxy radical. Chem Biol Interact 50:351
29. Liehr JG 1990 Genotoxic effects of estrogens. Mutat Res 238:269
30. Marks F, Hecker E 1969 Metabolism and mechanism of formation of water-soluble and protein-bond metabolites of oestrone in rat-liver microsomes in vitro and in vivo. Biochim Biophys Acta 187:250
31. Nelson SD, Mitchell TR, Dybing E, Sasame HA 1976 Cytochrome P-450 mediated oxidation 2-hydroxyestrogens to reactive intermediates. Biochem Biophys Res Commun 70:1157
32. Tsibris JCM, McGuire PM 1977 Microsomal actuation of estrogens and binding to nucleic acids and proteins. Biochem Biophys Res Commun 78:411
33. Horning EC, Thenot J-P, Helton ED 1978 Toxic agents resulting from the oxidative metabolism of steroid hormones and drugs. J Toxicol Environ Health 4:341
34. Liehr JG, Purdy RH, Baran JS, Nutting EF, Colton F, Randerath E, Randerath K 1987 Correlation of aromatic hydroxylation of 11β-substituted estrogens with morphological transformation in vitro but not with in vivo tumor induction by these hormones. Cancer Res 47:2583
35. Liehr JG 1983 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol Pharmacol 23:278
36. Liehr JG, Ballatore AM, McLachlan JA, Sirbasku DA 1983 Mechanism of diethylstilbestrol carcinogenicity as studied with the fluorinated analogue E-3’, 3–, 5’,5—-tetrafluorodiethylstilbestrol. Cancer Res 43:2678
37. Li JJ, Purdy RH, Appelman EH, Klicka JK, Li SA 1985 Catechol formation of fluoro-and bromo-substituted estradiol by hamster liver microsomes: evidence for dehalogenation. Mol Pharmacol 27:559
38. Hey MM, Haaf H, McLachlan JA, Metzler M 1986 Indirect evidence for the metabolic dehalogenation of tetrafluorodiethylstil-bestrol by rat and hamster liver and kidney microsomes. Species-and organ-dependent differences. Biochem Pharmacol 35:2135
39. Kaufman S 1961 The enzymic converion of 4-fluorophenylalanineto tyrosine. Biochim Biophys Acta 51:619
40. Daly JW, Guroff G, Udenfriend S, Witkop B 1968 Hydroxylation of alkyl and halogen substituted anilines and acetanilides by microsomal hydroxylases. Biochem Pharmacol 17:31
41. Scribner JD, Scribner NK, Koponen G 1982 Metabolism and nucleic acid binding of 7-fluor-2-acetamidofluorene in rats: oxidative defluorination and apparent dissociation from hepatocar-cinogenesis of 8(N-arylamide)guanine adducts on DNA. Chem Biol Interact 40:27
42. Buhler DR, Unlu F, Thakker DR, Slaga TJ, Conney AH, Wood AW, Chang RL, Levin W, Jerina DM 1983 Effect on a 6-fluoro substituent on the metabolism and biological activity of benzo(a)pyrene. Cancer Res 43:1541
43. Liehr JG, Stancel GM, Chorich LP, Bousfield GR, Ulubelen AA 1986 Hormonal carcinogenesis: separtion of estrogenicity from carcinogenicity. Chem Biol Interact 59:173
44. Roy D, Bui QD, Weisz J, Liehr JG 1989 Comparison of assays for catechol estrogen synthase activity: product isolation vs radioen-zymatic catechol-O-methyltransferase-coupled procedures. J Steroid Biochem 33:243
45. Roy D, Weisz J, Liehr JG 1990 The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis. Carcinogenesis 11:459
46. Purdy RH, Moore Jr PH, Williams JW, Goldzieher JW, Paul SM 1982 Relative rates of 2-and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. FEBS Lett 138:40
47. Li JJ, Oberley TD, Laucher J, Li SA, Further comparisons of the carcinogenic activities of various natural and synthetic estrogens in the hamster kidney: relation to cell proliferation in vitro. Cancer Res, in press
48. Ball P, Knuppen R, Haupt M, Breuer H 1972 Interactions between estrogens and catechol amines. III. Studies on the méthylation of catechol estrogens, catecholamines and other catechols by the catechol-O-methyltransferase of human liver. J Clin Endocrinol 34:736
49. Numazawa M, Nanbara T 1977 A new mechanism of in vitro formation of catechol estrogen glutathione conjugates by rat liver microsomes. J Steroid Biochem 8:835
50. Liehr JG, Avitts TA, Randerath E, Randerath K 1986 Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc Natl Acad Sci USA 83:5301
51. Liehr JG, Hall ER, Avitts TA, Randerath E, Randerath K 1987 Localization of estrogen-induced DNA adducts and cytochrome P-450 activity at the site of renal carcinogenesis in the hamster kidney. Cancer Res 47:2156
52. Liehr JG, Sirbasku DA, Jurka E, Randerath K, Randerath E 1988 Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamster by tamoxifen without decrease in DNA adduct levels. Cancer Res 48:779
53. Randerath K, Liehr JG, Gladek A, Randerath E 1989 Age-dependent covalent DNA alterations (I-compounds) in rodent tissues: species, tissue and sex spécificités. Mutat Res 219:121
54. Gonzalez A, Oberley TD, Li JJ 1989 Morphological and immuno-histochemical studies of the estrogen-induced Syrian hamster renal tumor: probable cell of origin. Cancer Res 49:1020
55. Gladek A, Liehr JG 1989 Mechanism of genotoxicity of diethylstilbestrol in vitro. J Biol Chem 264:16847
56. Li JJ, Li SA 1984 High incidence of hepatocellular carcinoma after synthetic estrogen administration in Syrian hamsters fed a-naph-thoflavone: a new tumor model. J Natl Cancer Inst 73:543
57. Li JJ, Talley DJ, Li SA, Villee CA 1974 An estrogen binding protein in the renal cytosol of the intact, castrated, and estrogen-ized golden hamster. Endocrinology 96:1106
58. Pantic V, Li JJ, Villee C 1974 Autoradiographic studies of the kidneys of hamsters bearing long term oestrogen implants. Cyto-biologie 9:89
59. Li SA, Li JJ 1979 Estrogen-induced progesterone receptor in the Syrian hamster kidney. I. Modulation by antiestrogens and androgens. Endocrinology 103:2119
60. Li JJ, Li SA 1981 Estrogen-induced progesterone receptor in the Syrian hamster kidney. II. Modulation by synthetic progestins. Endocrinology 108:1751
61. Oberley TD, Pugh TD, Gonzalez A, Goldfarb S, Li SA, Li JJ 1989 Specific estrogen-induced cell proliferation of cultured Syrian hamster proximal renal tubular cells in serum-free chemically defined media. Proc Natl Acad Sci 86:2107
62. Li JJ, Cuthbertson TL, Li SA 1977 Specific androgen binding in the kidney and estrogen-dependent renal carcinoma of the Syrian hamster. Endocrinology 101:1006
63. McGregor RF, Putch JD, Ward DN 1960 Estrogen-induced kidney tumors in the golden hamster. I. Biochemical composition during tumorigenesis. J Natl Cancer Inst 24:1057
64. Butterworth BE 1989 Nongenotoxic carcinogens in the regulatory environment. Regul Toxicol Pharmacol 9:244
65. Barrett JC, Oshimara M, Tanaka N, Tsutsui T 1987 Genetic and epigenetic mechanisms in carcinogeneses. In: Barrett JC (ed) Mechanisms of Environmental Carcinogenesis. CRC Press, Boca Raton, FL, vol 1:1
66. Barrett JC, Wong A, McLachlan JA 1981 Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science 212:1402
67. Tsutsui T, Degen GH, Schiffman D, Wong A, Maitzumi H, Mc Lachlan JA, Barrett JC 1984 Dependence on exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethylstilbestrol and related compounds. Cancer Res 44:184
68. Tsutsui T, Suzuki N, Maizumi H, McLachlan JA, Barrett JC 1986 Alteration in diethylstilbestrol-induced mutagenicity and cell transformation by exogenous metabolic activation. Carcinogenesis 7:1415
69. Epe B, Hegler J, Metzler M 1987 Site specific covalent binding of stilbene-type and steroidal estrogens to tubulin following metabolic activation in vitro. Carcinogenesis 8:1271
70. Epe B, Harttig UH, Schiffmann D, Metzler M 1989 Micro-tubular proteins as cellular targets for carcinogenic estrogens and other carcinogens. In: Mechanisms of Chromosome Distribution and Aneuploidy. Alan R. Liss Inc., New York, p 345
71. Yager JD, Yager R 1980 Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40:3680
72. Wanless IR, Medline A 1982 Role of estrogens as promoters of hepatic neoplasia. Lab Invest 46:313
73. Cameron R, Imaida K, Ito N 1981 Promotive effects of ethinyles tradiol in epatocarcinogenesis initiated by diethylnitrosamine in male rats. Gann 72:339
74. 2) on hepatic estrogen action in rats treated previously with diethylnitrosamine (DEN). The Toxicologist 4:37
75. 2) in rats treated previously with diethylnitrosamine (DEN). Fourth International Conference on Environmental Mutagens, Stockholm, Sweden, 1985
76. Gibson JP, Newberne JW, Kuhir WL, Elsea JR 1967 Comparative chronic toxicology of three oral estrogens in rats. Toxicol Appl Pharmacol 11:489
77. Schuppler J, Gunzel P 1979 Liver tumors and steroid hormones in rats and mice. ArchToxicol 2:181
78. Barrows GH, Christopherson WM, Drill VA 1977 Liver lesions and oral contraceptive steroids. J Toxicol Environ Health 3:219
79. Heston WE, Vialraleis G, Desmukes B 1973 Effect of the antifertility drug Enovid in female strains of mice with particular regard to carcinogenesis. J Natl Cancer Inst 51:209
80. El Etreby MF 1980 Influence of contraceptive steroids on tumor development in experimental animals and man: a short review. In: E Genazzani, et al., Ed. Pharmacological Modulation of Steroid Action. Raven Press, New York, p 239
81. Schardein JL, Kaump DH, Woosley ET, Jellems MM 1970 Long term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. Toxicol Appl Pharmacol 16:10
82. Higashi S, Tomita T, Mizumoto R, Nakakaki K 1980 Development of hepatomas in rats following oral administration of synthetic estrogen and progestogen. Gann 71:576
83. Yager JD, Campbell HA, Longnecker DS, Roebuck BD, Benoit MC 1984 Enhancement of hepatocarcinogenesis in female rats by ethinylestradiol and mestranol but not estradiol. Cancer Res 44:3862
84. Campen DB, Sloop TC, Maronpot RR, Lucier GW 1987 Continued development of hepatic glutamytranspeptidase-positive foci upon withdrawal of 17α-ethynylestradiol in diethylinitrosamine-initi-ated rats. Cancer Res 47:2328
85. Coe JE, Ishak KG, Ross MJ 1990 Estrogen induction of hepato cellular carcinomas in Armenian hamsters. Hepatology 11:570
86. Li SA, Li JJ 1981 Changes in estrogen receptor levels during DES-induced hepatocarcinogenesis in the Syrian hamster fed α-naph-thoflavone. J Steroid Biochem 15:387
87. Kohigashi K, Fukuda Y, Imura H 1988 Inhibitory effect of tamoxifen on diethylstilbestrol-promoted hepatic tumorigenesis in male rats and its possible mechanism of action. Jpn J Cancer Res 79:1335